Background/Objectives: Heat sensitivity in multiple sclerosis (MS) can worsen neurological symptoms and impair daily functioning and quality of life. As current cooling strategies are largely reactive, wearable technology may offer a proactive approach, provided it is acceptable to users. This pre-prototype study evaluated the perceived acceptability of a proposed ear-worn device, not yet fabricated, that would measure ear-site temperature and heart rate, alert the user, and direct localized airflow at the neck, and identified the user priorities that should guide its development. No technical feasibility or device-performance testing was performed. Methods: Adults with MS completed an electronic questionnaire on design preferences, functional features, and overall acceptability; a subset took part in semi-structured interviews analyzed thematically. Results: Forty-seven participants completed the survey. Comfort during prolonged use (72.3%) and compatibility with prescription glasses (66.0%) were the design features most often rated important; health reports (93.6%), communication with healthcare providers (91.5%), symptom monitoring (89.4%), emergency contact (85.1%), and automatic cooling activation (83.0%) were each rated important by more than 80% of participants, with overlapping confidence intervals that do not permit these functions to be ranked. Anticipated acceptability of the concept was uncertain: 46.8% (95% confidence interval [CI] 33.3–60.8) expressed some degree of acceptability (34.0% when only ‘acceptable’ or ‘very acceptable’ responses were counted), 36.2% were neutral, and 17.0% found it not acceptable. Six interviews generated four themes: uncertainty, the impact of heat on daily life, independence through self-management, and practical considerations for implementation. Conclusions: These findings reflect anticipated, concept-level acceptability rather than acceptability after use of a physical device. Because the proposed device would measure ear-site temperature and heart rate rather than neurological symptoms, the priority given to symptom monitoring is addressed through physiological early warning combined with user-reported symptoms. The identified priorities are translated into measurable specifications and verification tests for the next prototype; the technical performance of the device, including its cooling capacity, remains to be demonstrated.
No takes yet. Share an insight, caveat, or question.
Almuwais et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: